文献速递流行病学与生物统计真实世界研究与卫生经济

疫苗接种不足与重型COVID-19结局:英格兰、北爱尔兰、苏格兰和威尔士全国性队列研究的荟萃分析

Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
PubMed 文献 · Lancet · 2024-01-15

该研究利用英格兰、北爱尔兰、苏格兰和威尔士全人群电子健康记录开展队列研究,估计2022年6月1日疫苗接种不足的调整比值比,以及2022年6月1日至9月30日期间疫苗接种不足(作为时变暴露)与重型COVID-19结局的调整风险比,并进行英国范围固定效应荟萃分析。结果显示四国疫苗接种不足率为32.8%至49.8%,疫苗接种不足与重型COVID-19结局风险升高相关。

要点

  • 2022年6月1日疫苗接种不足率:英格兰45.8%、北爱尔兰49.8%、苏格兰34.2%、威尔士32.8%。
  • 较年轻、更贫困背景、非白人 ethnicity 或合并症较少者更不可能完成全程接种。
  • 75岁及以上人群荟萃分析中,少接种1至4剂次的调整风险比为2.70至3.61。

核心结论

  • 2022年夏季英国四国COVID-19疫苗接种不足率为32.8%至49.8%,疫苗接种不足与重型COVID-19结局风险升高相关。

研究设计与样本

  • 在英格兰、北爱尔兰、苏格兰和威尔士利用匿名、统一的全人群电子健康记录数据开展队列研究,纳入至少5岁人群。
  • 估计2022年6月1日疫苗接种不足的调整比值比,以及2022年6月1日至9月30日期间以疫苗接种不足为时变暴露的重型COVID-19结局调整风险比。
  • 将各国分析结果在英国范围固定效应荟萃分析中合并,并估计若2022年6月1日全英国均完成全程接种的反事实情景下重型COVID-19结局的减少数。

主要发现

  • 2022年6月1日疫苗接种不足人数:英格兰26 985 570/58 967 360(45.8%)、北爱尔兰938 420/1 885 670(49.8%)、苏格兰1 709 786/4 992 498(34.2%)、威尔士773 850/2 358 740(32.8%)。
  • 较年轻、来自更贫困背景、非白人 ethnicity 或合并症数量较少者更不可能完成全程接种。
  • 队列中共有40 393例重型COVID-19结局,其中14 156例发生在疫苗接种不足参与者中。
  • 若2022年6月1日全英国均完成全程接种,4个月随访期间重型COVID-19结局减少数:5-15岁年龄组210(95%CI 94-326)、16-74岁年龄组1544(95%CI 1399-1689)、75岁及以上年龄组5426(95%CI 5340-5512)。
  • 75岁及以上年龄组荟萃分析中,重型COVID-19结局的调整风险比:少接种1剂次2.70(95%CI 2.61-2.78)、少2剂次3.13(95%CI 2.93-3.34)、少3剂次3.61(95%CI 3.13-4.17)、少4剂次3.08(95%CI 2.89-3.29)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Undervaccination (receiving fewer than the recommended number of SARS-CoV-2 vaccine doses) could be associated with increased risk of severe COVID-19 outcomes-ie, COVID-19 hospitalisation or death-compared with full vaccination (receiving the recommended number of SARS-CoV-2 vaccine doses). We sought to determine the factors associated with undervaccination, and to investigate the risk of severe COVID-19 outcomes in people who were undervaccinated in each UK nation and across the UK. METHODS: We used anonymised, harmonised electronic health record data with whole population coverage to carry out cohort studies in England, Northern Ireland, Scotland, and Wales. Participants were required to be at least 5 years of age to be included in the cohorts. We estimated adjusted odds ratios for undervaccination as of June 1, 2022. We also estimated adjusted hazard ratios (aHRs) for severe COVID-19 outcomes during the period June 1 to Sept 30, 2022, with undervaccination as a time-dependent exposure. We combined results from nation-specific analyses in a UK-wide fixed-effect meta-analysis. We estimated the reduction in severe COVID-19 outcomes associated with a counterfactual scenario in which everyone in the UK was fully vaccinated on June 1, 2022. FINDINGS: The numbers of people undervaccinated on June 1, 2022 were 26 985 570 (45·8%) of 58 967 360 in England, 938 420 (49·8%) of 1 885 670 in Northern Ireland, 1 709 786 (34·2%) of 4 992 498 in Scotland, and 773 850 (32·8%) of 2 358 740 in Wales. People who were younger, from more deprived backgrounds, of non-White ethnicity, or had a lower number of comorbidities were less likely to be fully vaccinated. There was a total of 40 393 severe COVID-19 outcomes in the cohorts, with 14 156 of these in undervaccinated participants. We estimated the reduction in severe COVID-19 outcomes in the UK over 4 months of follow-up associated with a counterfactual scenario in which everyone was fully vaccinated on June 1, 2022 as 210 (95% CI 94-326) in the 5-15 years age group, 1544 (1399-1689) in those aged 16-74 years, and 5426 (5340-5512) in those aged 75 years or older. aHRs for severe COVID-19 outcomes in the meta-analysis for the age group of 75 years or older were 2·70 (2·61-2·78) for one dose fewer than recommended, 3·13 (2·93-3·34) for two fewer, 3·61 (3·13-4·17) for three fewer, and 3·08 (2·89-3·29) for four fewer. INTERPRETATION: Rates of undervaccination against COVID-19 ranged from 32·8% to 49·8% across the four UK nations in summer, 2022. Undervaccination was associated with an elevated risk of severe COVID-19 outcomes. FUNDING: UK Research and Innovation National Core Studies: Data and Connectivity.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales. Lancet. 2024. PMID: 38237625. doi:10.1016/S0140-6736(23)02467-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。